Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2010
12/08/2010EP2258399A2 Multivalent VLA-4 antagonists comprising polymer moieties
12/08/2010EP2258392A1 Method of administering therapeutic polypeptides
12/08/2010EP2258390A1 Improved bacterial outer membrane vesicles
12/08/2010EP2258387A2 Neisseria vaccine composition
12/08/2010EP2258386A2 Neisseria Vaccine composition
12/08/2010EP2258385A2 Neisseria vaccine composition
12/08/2010EP2258384A2 Neisseria vaccine composition
12/08/2010EP2258383A2 Antigenic peptides derived from telomerase
12/08/2010EP2258380A1 Substance and composition both capable of imparting heat resistance
12/08/2010EP2258377A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids
12/08/2010EP2258365A1 Use of organic compounds for immunopotentiation
12/08/2010EP2258363A1 Compositions for treatment of cancers
12/08/2010EP2258361A1 Use of benzophenone derivative or salt thereof and tnf inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
12/08/2010EP2257568A1 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use
12/08/2010EP2257552A1 Heterocyclic compounds as inhibitors of cxcr2
12/08/2010EP2257536A2 Cyclic diaryl ether as antagonists of prostaglandin d2 receptors
12/08/2010EP2257529A2 Pyridines and pyrazines as inhibitors of pi3k
12/08/2010EP2257527A1 Substituted sulfonamide derivatives
12/08/2010EP2257301A2 Allogeneic cancer cell-based immunotherapy
12/08/2010EP1853254B1 Cytokine modulators using cyclic glycerides of essential polyunsaturated fatty acids
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1496109B1 Process for producing cytotoxic lymphocyte
12/08/2010EP1395284B1 Non-depleting anti-CD4 antibody TRX1 and its uses
12/08/2010EP1389997B1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
12/08/2010EP1322318B1 Use of probiotic lactic acid bacteria for preventing ultraviolet radiation induced inflammatory or allergic reaction or immunosuppression in the skin
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1977892B Method for regulating baicalin and baicalein ratio in scutellariae root extract
12/08/2010CN1948475B Recombination expression carrier for treating Aids, reformed blood building stem cell and method
12/08/2010CN1943674B Nettle prodigiosin powders
12/08/2010CN1778294B Butin and its derivative and its use in preparation of pigmental metabolic disease medicine
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1384884B Herpes virus vectors for dendritic cells
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
12/08/2010CN101910155A Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto
12/08/2010CN101909646A Allergy vaccine composition for mucosal administration
12/08/2010CN101909644A Prevention of opportunistic infections in immune-compromised subjects
12/08/2010CN101909643A Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
12/08/2010CN101909640A Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly
12/08/2010CN101909636A Use of oligosaccharides containing N-acetyllactosamine for maturation of immune responses in neonates
12/08/2010CN101909611A Compositions and methods for enhancing immune response
12/08/2010CN101909609A Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
12/08/2010CN101906464A Proteins producing an altered immunogenic response and methods of making and using the same
12/08/2010CN101906418A Promoter for introducing gene into lymphocyte or blood cell and application thereof
12/08/2010CN101906106A Novel heterocyclic compounds as HSP90-inhibitors
12/08/2010CN101906104A 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
12/08/2010CN101906076A Naphthaline amide derivative serving as protein kinase inhibitor and histone deacetylase inhibitor and preparation method and application thereof
12/08/2010CN101906071A Dioxane-2-alkyl carbamates derivatives
12/08/2010CN101905023A Method of effectively using medicine and method concerning prevention of side effect
12/08/2010CN101905022A Stable medicinal composition containing artemisia pollen allergen and preparation method thereof
12/08/2010CN101904953A Medicinal composition for diminishing inflammation and relieving pain and preparation method and use thereof
12/08/2010CN101904941A Formula of traditional Chinese medicine for treating immune infertility
12/08/2010CN101904938A Kidney-tonifying heath traditional Chinese medicine composition and preparation method thereof
12/08/2010CN101904902A Immunity enhancement taking Japanese hop as main formula
12/08/2010CN101904885A Medicinal composition for treating allergic rhinitis and preparation method and application thereof
12/08/2010CN101904874A Medicinal composition having effect of enhancing immunologic functions
12/08/2010CN101904873A Medicament taking haematococcus pluvialis as raw material
12/08/2010CN101904864A Application of silicone oil in preparing allergen retarder
12/08/2010CN101904863A Preparation process of medicinal composition compounded from astragaloside and astragalus polyose
12/08/2010CN101904861A Application of Saccharomyces cerevisiae RNA in preparing medicine for promoting biologic metabolism and immunity
12/08/2010CN101904856A Application of 1,6-diphosphofructose and derivative thereof in preparing animal medical health care products
12/08/2010CN101904855A Anti-anaphylaxis and sterilization combined injection
12/08/2010CN101904848A Use of HIF alpha stabilizers for enhancing erythropoiesis
12/08/2010CN101904833A Salvianic acid A medical composition and preparation method thereof
12/08/2010CN101904821A Quercetin nano freeze-dried powder and preparation method thereof
12/08/2010CN101904820A Quercetin nanosuspension freeze-drying composition and preparation method and application thereof
12/08/2010CN101904819A Method for preparing taurine particles
12/08/2010CN101537003B Application of 7,3'-dimethoxy hesperetin in preparation of anti-inflammatory immune medicaments
12/08/2010CN101461895B Medicament composition for treating female climacteric syndrome and delaying age
12/08/2010CN101461624B Method for producing summer sleeping mat using vitamin C and vitamin E to build up resistance
12/08/2010CN101367881B High-efficiency preparation method for glossy ganoderma polysaccharide
12/08/2010CN101366914B Medicament for tumour restraint, anti-hunger, detoxication, reinforcing phylactic power and preparation method
12/08/2010CN101365463B Antacid
12/08/2010CN101353383B Water-soluble yeast beta-dextran and preparation thereof
12/08/2010CN101347418B Use of 8-0-4'type lignan in preparing anticomplement medicament
12/08/2010CN101301459B Medicated pillow
12/08/2010CN101288767B Chinese traditional medicine for control of recurrent respiratory tract infection and assisted-therapy of tumor and its preparation method
12/08/2010CN101249157B Traditional Chinese medicine preparation for improving chicken immunity and antioxidant ability
12/08/2010CN101167918B Traditional Chinese medicinal preparation for increasing immunity of pig or poultry
12/08/2010CN101165070B A series of fusion protein with dual biological activity and medical treatment thereof
12/08/2010CN101095447B Health-care coffee having waste-discharging and youth-keeping function and the preparing method thereof
12/08/2010CN101072752B Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
12/08/2010CN101045745B Scale preparation method of bursin and application of used as avian influema vaccine adjuvant
12/07/2010US7847109 Triptolide derivatives for modulation of apoptosis and immunosuppression
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846487 A neutraceutical comprising a dehydrated product of Type II collagen that retains its original natural structure and biological activity, sodium or potassium chloride and water; nonhydrolyzing; storage stability; antiarthritic agents;tablets; capsules; cream; lotion; biodrug; food supplements
12/07/2010US7846468 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/07/2010US7846442 Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
12/07/2010US7845348 Methods for treating trigeminal neuralgia
12/07/2010US7845347 Methods for treating headaches
12/07/2010CA2514816C Use of alpha-1 antitrypsin for the preparation of medicaments for the treatment of fibromyalgia
12/07/2010CA2488334C 24-sulfoximine vitamin d3 compounds
12/07/2010CA2471883C Phenylpyrimidine amines as ige inhibitors
12/07/2010CA2468542C Synthesis of 2-cyanoaziridine-1-carboxamide
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2417570C Tumor-specific t cell activation by peptide antigens
12/07/2010CA2398335C Herpes virus strains